BOULDER, Colo., May 29, 2019 /PRNewswire/ -- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, today announced the appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the...
from PR Newswire: https://prn.to/2Mudndx
No comments:
Post a Comment